What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis

Journal of Gastroenterology and Hepatology (Australia) - Tập 27 Số s2 - Trang 65-68 - 2012
Keiko Iwaisako1, David A. Brenner2, Tatiana Kisseleva2
1Department of Medicine, University of California, San Diego, La Jolla, California 92093-0602, USA.
2Department of Medicine, University of California, San Diego, La Jolla, California, USA

Tóm tắt

Abstract

Chronic liver injury of many etiologies produces liver fibrosis and may eventually lead to the formation of cirrhosis. Fibrosis is part of a dynamic process associated with the continuous deposition and resorption of extracellular matrix, mainly fibrillar collagen. Studies of fibrogenesis conducted in many organs including the liver demonstrate that the primary source of the extracellular matrix in fibrosis is the myofibroblast. Hepatic myofibroblasts are not present in the normal liver but transdifferentiate from heterogeneous cell populations in response to a variety of fibrogenic stimuli. Debate still exists regarding the origin of hepatic myofibroblasts. It is considered that hepatic stellate cells and portal fibroblasts have fibrogenic potential and are the major origin of hepatic myofibroblasts. Depending on the primary site of injury the fibrosis may be present in the hepatic parenchyma as seen in chronic hepatitis or may be restricted to the portal areas as in most biliary diseases. It is suggested that hepatic injury of different etiology triggers the transdifferentiation to myofibroblasts from distinct cell populations. Here we discuss the origin and fate of myofibroblast in liver fibrosis.

Từ khóa


Tài liệu tham khảo

10.1172/JCI24282

10.1172/JCI30542

10.1038/ncpgasthep1200

10.1002/hep.20974

10.1513/pats.200711-168DR

10.1172/JCI39675

Choi SS, 2009, Epithelial‐to‐mesenchymal transitions in the liver, Hepatology, 13, 565

10.1038/nm1613

10.1681/ASN.2008050513

10.1111/j.1440-1746.2006.04584.x

10.1172/JCI200320530

10.1189/jlb.0906587

10.4049/jimmunol.178.8.5288

10.1016/j.mam.2007.09.002

10.1111/j.1582-4934.2007.00213.x

10.1055/s-2001-17550

10.1083/jcb.200701040

10.1002/hep.22701

10.1016/S0083-6729(06)75006-3

Tuchweber B, 1996, Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat, Lab. Invest., 74, 265

Guyot C, 2006, Hepatic fibrosis and cirrhosis: the (myo) fibroblastic cell subpopulations involved, Int. J. Biochem. Cell Biol., 38, 135

10.1097/01.LAB.0000054178.01162.E4

10.1038/labinvest.3700513

10.1016/S0014-5793(04)00037-7

10.1016/S0016-5085(99)70407-5

10.1007/s00441-007-0437-z

10.1002/hep.23012

10.1002/pmic.200900257

10.1053/j.gastro.2004.02.025

10.1053/j.gastro.2006.01.036

10.1172/JCI200418847

10.3181/0707-MR-190

10.1053/j.gastro.2009.08.026

10.1096/fj.03-1100fje

10.1097/TP.0b013e3181938998

10.1007/978-1-59745-060-7_16

10.1038/328429a0

10.1016/j.jhep.2006.04.014

10.1681/ASN.2010060616

10.1002/hep.23368

10.1002/hep.24206